Dermira_Logo_RGB_R4V2_M01.jpg
Dermira Receives FDA Approval for Qbrexza™ (glycopyrronium) Cloth to Treat Primary Axillary Hyperhidrosis
29 juin 2018 07h00 HE | Dermira, Inc.
Qbrexza is the first FDA-approved, once-daily, topical prescription treatment indicated for people with primary axillary hyperhidrosis, also known as excessive underarm sweating The chronic, medical...
Dermira_Logo_RGB_R4V2_M01.jpg
Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08 juin 2018 16h01 HE | Dermira, Inc.
MENLO PARK, Calif., June 08, 2018 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering...
Dermira_Logo_RGB_R4V2_M01.jpg
Dermira to Present at Jefferies 2018 Global Healthcare Conference
30 mai 2018 16h01 HE | Dermira, Inc.
MENLO PARK, Calif., May 30, 2018 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering...
Dermira_Logo_RGB_R4V2_M01.jpg
Dermira to Host Analyst & Investor Day on May 24, 2018
14 mai 2018 08h30 HE | Dermira, Inc.
MENLO PARK, Calif., May 14, 2018 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering...
Dermira_Logo_RGB_R4V2_M01.jpg
Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08 mai 2018 16h03 HE | Dermira, Inc.
MENLO PARK, Calif., May 08, 2018 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering...
Dermira_Logo_RGB_R4V2_M01.jpg
Dermira Reports First Quarter 2018 Financial Results and Provides Corporate Update 
03 mai 2018 16h02 HE | Dermira, Inc.
FDA decision on glycopyrronium tosylate New Drug Application expected by June 30, 2018Lebrikizumab Phase 2b study enrolling patients, data expected in first half of 2019 MENLO PARK, Calif., May 03,...
Dermira and Cameran Eubanks Team Up to Raise Awareness of Excessive Sweating for the 15 Million People Living with the Condition in the U.S.
02 mai 2018 08h00 HE | Dermira, Inc.
MENLO PARK, Calif., May 02, 2018 (GLOBE NEWSWIRE) -- Reality television personality Cameran Eubanks and Dermira, Inc. (NASDAQ:DERM) announced today that they are collaborating on a new educational...
Dermira_Logo_RGB_R4V2_M01.jpg
Dermira to Present at Deutsche Bank 43rd Annual Healthcare Conference
01 mai 2018 16h02 HE | Dermira, Inc.
MENLO PARK, Calif., May 01, 2018 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering...
Dermira_Logo_RGB_R4V2_M01.jpg
Christopher Horan Joins Dermira as Chief Technical Operations Officer
19 avr. 2018 16h04 HE | Dermira, Inc.
Previously served as Senior Vice President, Global Product and Supply Chain Management at Genentech, Inc. (Roche)Brings more than 25 years of biopharma operations experience to Dermira    MENLO...
Dermira_Logo_RGB_R4V2_M01.jpg
Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11 avr. 2018 16h05 HE | Dermira, Inc.
MENLO PARK, Calif., April 11, 2018 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering...